CIBC Bancorp USA’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
+1,885
New +$280K ﹤0.01% 1451
2025
Q3
$336K Buy
+3,437
New +$277K ﹤0.01% 1035

Other funds holding ACLS

CIBC Bancorp USA's ACLS Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Axcelis (ACLS) in Q2 2026: 1,885 shares worth $357K. The stake represents ﹤0.01% of the portfolio and ranks #1451 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in ACLS as recently as Q3 2025.

CIBC Bancorp USA first reported a position in ACLS in Q3 2025 and has held it in 2 quarters since. 442 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • CIBC Bancorp USA held 1,885 shares of Axcelis worth $357K as of Q2 2026.
  • Axcelis was a new CIBC Bancorp USA position in Q2 2026.
  • Axcelis made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1451 holding.
  • CIBC Bancorp USA first reported a position in Axcelis in Q3 2025 and has held it in 2 quarters since.
  • 442 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.